✦ LIBER ✦

Efficacy and Safety of Prolonged Immunomodulatory Treatment with Interferon Beta

✍ Scribed by T. L. Demina; N. V. Khachanova; M. V. Davydovskaya; N. F. Popova; E. I. Gusev

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 583 KB
Volume: 39
Category: Article
ISSN: 0097-0549
DOI: 10.1007/s11055-009-9151-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of prolonged amlodip

Efficacy and safety of prolonged amlodipine treatment in hypertensive children

✍ Joseph T. Flynn 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 133 KB

Interferon alfa for chronic hepatitis B

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

✍ Harry L. Janssen; Guido Gerken; Vicente Carreño; Patrick Marcellin; Nikolai V. N 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Long-term efficacy and safety of interfe

Long-term efficacy and safety of interferon-alpha-2B in patients with mumps orchitis

✍ Turgut Yapanoglu; Huseyin Kocaturk; Yilmaz Aksoy; Fatih Alper; Isa Ozbey 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 151 KB

Efficacy and safety of cefprozil versus

Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections

✍ P. Ball 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 584 KB

Interferon alfa-2b in combination with r

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh

Growth hormone treatment of infants with

Growth hormone treatment of infants with chronic kidney disease: requirement, efficacy, and safety

✍ Dieter Haffner; Dagmar-Christiane Fischer 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 95 KB